Medtronic launches Kinetra in Europe and Canada:
This article was originally published in Clinica
Medtronic has announced the European and Canadian launch of the Kinetra neurostimulator, an implantable device to block errant brain signals that cause symptoms of Parkinson's disease or essential tremor. The device delivers Medtronic's Activa Parkinson's and tremor control therapy and is used with the hand-held Access therapy controller, aimed to give patients more control over treatment. Before Kinetra, treatment required the implantation of two neurostimulators. The company says over one million Europeans suffer from Parkinson's disease and essential tremor also affects one million people in Europe.